Belimumab Vials and Emtricitabine, rilpivirine, and tenofovir
Determining the interaction of Belimumab Vials and Emtricitabine, rilpivirine, and tenofovir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: belimumab
Brand name: Benlysta, Benlysta Autoinjector
Synonyms: Belimumab
Generic Name: emtricitabine / rilpivirine / tenofovir
Brand name: Complera, Odefsey
Synonyms: Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Belimumab Vials-Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
- Belimumab Vials-Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- Belimumab Vials-Emtriva
- Belimumab Vials-Emtriva (Emtricitabine Capsules)
- Belimumab Vials-Emtriva (Emtricitabine Solution)
- Belimumab Vials-Emverm
- Emtricitabine, rilpivirine, and tenofovir-Belinostat
- Emtricitabine, rilpivirine, and tenofovir-Belinostat Intravenous
- Emtricitabine, rilpivirine, and tenofovir-Belladonna
- Emtricitabine, rilpivirine, and tenofovir-Belladonna alkaloids and phenobarbital
- Emtricitabine, rilpivirine, and tenofovir-Belladonna and Opium
- Emtricitabine, rilpivirine, and tenofovir-Belladonna and opium rectal